OCD Trial, Recruiting NCT03953014 Sponsor: University of Calgary Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT03953014
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 6 and 24 years old
  • Your medical records are available for review
  • You have been diagnosed with depression (MDD), an anxiety disorder, or OCD (obsessive-compulsive disorder)
  • You are currently taking, or have previously taken, a type of antidepressant medication called an SSRI

Who may not be able to join:

  • Your parent or legal guardian is unable or unwilling to give formal consent for you to take part
  • You (as the young person) are unable to give your own agreement to take part
  • You are unwilling to provide a saliva sample for genetic testing
  • You have been diagnosed with, or are suspected of having, ADHD, oppositional defiant disorder, conduct disorder, bipolar disorder, a psychotic disorder, or a pervasive developmental disorder (such as autism) — either now or in the past

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chad Bousman, PhD, University of Calgary

Phone: 5875739747

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Calgary
Registry
ClinicalTrials.gov
Start date
2 January 2019
Est. completion
30 September 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Genetic variants in SSRI metabolism; Behavioural Disinhibition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov